Concepedia
Statistics
Publications
22
Citations
578
H-Index
15
Active since
1990
Affiliations
Saiseikai Kumamoto Hospital(Current)
Kobe City Medical Center General Hospital
National Hospital Organization
Osaka International Cancer Institute
Wakayama Medical University
Yoshihiko Sakata is an author at Saiseikai Kumamoto Hospital specializing in medicine, oncology, and pharmacology.
Publications per year
1990–2023
Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation–positive non–small-cell lung cancer in a real-world setting (OSI-FACT)
Yoshihiko Sakata, Shinya Sakata, Yuko Oya et al. · European Journal of Cancer · 2021 · 89 citations
Medicine, Oncology, Pharmacology +12
Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON)
Go Saito, Yuko Oya, Yoshihiko Taniguchi et al. · Lung Cancer · 2021 · 58 citations
Medicine, Oncology, Radiation Oncology +15
The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatment
Yoshihiko Sakata, Kodai Kawamura, Kazuya Ichikado et al. · Lung Cancer · 2019 · 43 citations
Life Sciences, Immunology, Oncology +17
Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysis
Kodai Kawamura, Kazuya Ichikado, Makoto Takaki et al. · SpringerPlus · 2016 · 40 citations · Full text
Medicine, Pharmacotherapy, Antimicrobial Pharmacotherapy +16
Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer
Yuki Sato, Hiromitsu Sumikawa, Ryota Shibaki et al. · CHEST Journal · 2022 · 40 citations
1–5 of 22